Dr. Perlin is the current CSO of Center for Development and Innovation at Hackensack Meridian Health. Previously he was the Executive Director of the Rutgers/New Jersey Medical School’s Public Health Research Institute (PHRI), a 72 year old specialized center for global infectious diseases research. He is also Director of the Rutgers Regional Biocontainment Laboratory, one of thirteen NIH-designated national centers, and a Professor of Microbiology and Molecular Genetics. Dr. Perlin helped establish PHRI as a leading tuberculosis and opportunistic infections research organization. His primary expertise is in fungal infections, mechanisms of antifungal drug resistance, and rapid diagnosis of opportunistic drug resistant bacetrial and fungal pathogens in high-risk patients.
He has published more than 175 papers and book chapters and has co-authored two books. His laboratory is supported by grants from the NIH, pharma and biotech sectors. He is on the editorial board of several scientific journals and serves on the Board of Directors of the Aaron Diamond AIDS Research Center, and Scientific/Medical Advisory Boards for the CLSI, pharma and biotech companies, and PinnacleCare. He is also a member of the New York City Department of Health and Mental Hygiene Advisory Panel on Bioterrorism and Emerging Infections, the Executive Committee of the Northeast Biodefense Center, and Steering Committee for Microbiology, Immunology & Infectious Diseases of the New York Academy of Sciences.